Lipoproteins in Atherosclerosis Process

Author(s): Valentina Arnao, Antonino Tuttolomondo*, Mario Daidone, Antonio Pinto.

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 9 , 2019

  Journal Home
Translate in Chinese
Submit Manuscript
Submit Proposal

Abstract:

Background: Dyslipidaemias is a recognized risk factor for atherosclerosis, however, new evidence brought to light by trials investigating therapies to enhance HDLcholesterol have suggested an increased atherosclerotic risk when HDL-C is high.

Results: Several studies highlight the central role in atherosclerotic disease of dysfunctional lipoproteins; oxidised LDL-cholesterol is an important feature, according to “oxidation hypothesis”, of atherosclerotic lesion, however, there is today a growing interest for dysfunctional HDL-cholesterol. The target of our paper is to review the functions of modified and dysfunctional lipoproteins in atherogenesis.

Conclusion: Taking into account the central role recognized to dysfunctional lipoproteins, measurements of functional features of lipoproteins, instead of conventional routine serum evaluation of lipoproteins, could offer a valid contribution in experimental studies as in clinical practice to stratify atherosclerotic risk.

Keywords: Lipoproteins, oxidised, dysfunctional, atherogenisis, dyslipidemia, HDL-C, atherosclerosis.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 26
ISSUE: 9
Year: 2019
Page: [1525 - 1543]
Pages: 19
DOI: 10.2174/0929867326666190516103953
Price: $58

Article Metrics

PDF: 15